| Literature DB >> 30518949 |
Zhihua Ren1, Yu Fan1, Zhuo Zhang1, Chaoxi Chen2, Changhao Chen1, Xuemei Wang1, Junliang Deng1, Guangneng Peng1, Yanchun Hu1, Suizhong Cao1, Shumin Yu1, Xiaoping Ma1, Liuhong Shen1, Zhijun Zhong1, Ziyao Zhou1, Zhiwen Xu1, Zhicai Zuo3.
Abstract
Deoxynivalenol (DON) is a cytotoxic mycotoxin that can cause cell damages. The main effect is to inhibit protein synthesis. Oxidative stress is one of the effects of DON. Selenium (Se) can ameliorate the cell damage caused by DON-induced oxidative stress, but it is unclear whether through selenoprotein glutathione peroxidase 1 (GPX1). We established GPX1-knockdown porcine spleen lymphocytes, and treated them with DON and Se. Untransfected porcine splenic lymphocytes (group P) and transfected cells (group M, GPX1 knockdown) were treated with or without DON (0.824, 0.412, 0.206, or 0.103 μg/mL, group D1-4), Se (Na2SeO3, 2 μM, group Se), or both (group SD1-4) for 6, 12, or 24 h. The cells were collected and the activities of SOD and CAT, levels of GSH, H2O2, malonaldehyde (MDA), total antioxidant capacity (T-AOC), and the inhibition of free hydroxyl radicals were determined. Levels of ROS were measured at 24 h. Compared with group P, the antioxidant capacity of group M was reduced. DON caused greater oxidative damage to the GPX1-knockdown porcine splenic lymphocytes than to the normal control cells. When Na2SeO3 was combined with DON, it reduced the damage in the GPX1-knockdown porcine splenic lymphocytes, but less effectively than in the normal porcine splenic lymphocytes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30518949 PMCID: PMC6281670 DOI: 10.1038/s41598-018-36149-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Transfection efficiency of GPX1-directed siRNA in porcine splenic lymphocytes. the blank control shown in (A), the transfection efficiency of combination was 51.1% + 0.8% shown in (B), the transfection efficiency of combination was 71.3% + 1.3% shown in (C), the transfection efficiency of combination was 80.6% + 1.7% shown in (D), and the transfection efficiency of combination was 92.9% + 2% shown in (E). Therefore, we selected combination E for the subsequent experiment.
Relative expression of GPX1 mRNA.
| Groups | Control siRNA | Scrambled siRNA | Control |
|---|---|---|---|
| Relative expression (%) | 28.4 ± 3.2 | 99.4 ± 4.8 | 100 ± 1.7 |
Figure 2Relative expression of GPX1 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) proteins. Its show that there was no significant difference in the expression of GAPDH between the normal and knockdown groups. However, the expression of GPX1 differed significantly between the normal control and knockdown groups, and that GPX1-knockdown cells expressed only 36.9% of the GPX1 expressed by the normal group. Therefore, the knockdown efficiency was 63.1%. ##P < 0.01. Table 1. the expression of GPX1 in the group of cells treated with the control GPX1-directed siRNA was 28.4% of that in the control group, whereas the expression of GPX1 in the scrambled siRNA group was 99.4% of that in the control group. This suggests that there was no nonspecific gene silencing.
Effects of DON and/or Na2SeO3 on the levels of H2O2 in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment
| H2O2 (mmol/gprot) | ||||
|---|---|---|---|---|
| time | pairing | content |
| |
| 6 h | P — M | 10.978 ± 0.387 | 13.964 ± 0.730 | 0.004 |
| M — Se | 13.964 ± 0.730 | 12.526 ± 0.422 | 0.015 | |
| M — D1 | 13.964 ± 0.730 | 19.719 ± 0.970 | 0.001 | |
| M — D2 | 13.964 ± 0.730 | 16.845 ± 0.269 | 0.008 | |
| M — D3 | 13.964 ± 0.730 | 15.823 ± 0.415 | 0.009 | |
| M — D4 | 13.964 ± 0.730 | 14.527 ± 0.632 | 0.010 | |
| D1 — SD1 | 19.719 ± 0.970 | 19.341 ± 1.271 | 0.162 | |
| D2 — SD2 | 16.845 ± 0.269 | 16.291 ± 0.732 | 0.174 | |
| D3 — SD3 | 15.823 ± 0.415 | 15.037 ± 0.324 | 0.004 | |
| D4 — SD4 | 14.527 ± 0.632 | 13.639 ± 0.283 | 0.048 | |
| 12 h | P — M | 12.206 ± 0.513 | 17.757 ± 0.815 | 0.001 |
| M — Se | 17.757 ± 0.815 | 15.617 ± 0.689 | 0.001 | |
| M — D1 | 17.757 ± 0.815 | 30.445 ± 1.663 | 0.001 | |
| M — D2 | 17.757 ± 0.815 | 26.350 ± 1.513 | 0.002 | |
| M — D3 | 17.757 ± 0.815 | 23.882 ± 1.438 | 0.003 | |
| M — D4 | 17.757 ± 0.815 | 21.540 ± 1.633 | 0.015 | |
| D1 — SD1 | 30.445 ± 1.663 | 29.654 ± 1.513 | 0.012 | |
| D2 — SD2 | 26.350 ± 1.513 | 24.767 ± 1.168 | 0.015 | |
| D3 — SD3 | 23.882 ± 1.438 | 22.273 ± 0.784 | 0.051 | |
| D4 — SD4 | 21.540 ± 1.633 | 20.593 ± 0.816 | 0.182 | |
| 24 h | P — M | 19.759 ± 0.973 | 25.341 ± 1.110 | <0.001 |
| M — Se | 25.341 ± 1.110 | 22.547 ± 0.754 | 0.005 | |
| M — D1 | 25.341 ± 1.110 | 35.623 ± 1.581 | 0.001 | |
| M — D2 | 25.341 ± 1.110 | 32.710 ± 1.750 | 0.003 | |
| M — D3 | 25.341 ± 1.110 | 28.664 ± 1.372 | 0.002 | |
| M — D4 | 25.341 ± 1.110 | 27.633 ± 1.038 | <0.001 | |
| D1 — SD1 | 35.623 ± 1.438 | 33.779 ± 1.384 | 0.004 | |
| D2 — SD2 | 32.710 ± 1.309 | 30.053 ± 1.268 | 0.011 | |
| D3 — SD3 | 28.664 ± 1.025 | 24.524 ± 1.082 | 0.002 | |
| D4 — SD4 | 27.633 ± 1.016 | 22.240 ± 1.120 | <0.001 | |
Effects of DON and/or Na2SeO3 on the cellular capacity to inhibit hydroxyl radicals in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| The capacity of inhibing effect of hydroxyl radical (U/mg.prot) | ||||
|---|---|---|---|---|
| time | pairing | numerical |
| |
| 6 h | P — M | 192.734 ± 6.195 | 173.766 ± 4.325 | 0.003 |
| M — Se | 173.766 ± 4.325 | 177.184 ± 3.675 | 0.012 | |
| M — D1 | 173.766 ± 4.325 | 110.845 ± 3.445 | <0.001 | |
| M — D2 | 173.766 ± 4.325 | 116.058 ± 2.265 | <0.001 | |
| M — D3 | 173.766 ± 4.325 | 142.478 ± 3.595 | <0.001 | |
| M — D4 | 173.766 ± 4.325 | 170.113 ± 4.335 | <0.001 | |
| D1 — SD1 | 110.845 ± 3.445 | 111.664 ± 3.685 | 0.027 | |
| D2 — SD2 | 116.058 ± 2.265 | 117.824 ± 3.725 | 0.171 | |
| D3 — SD3 | 142.478 ± 3.595 | 146.309 ± 3.480 | <0.001 | |
| D4 — SD4 | 170.113 ± 4.335 | 171.357 ± 3.805 | 0.056 | |
| 12 h | P — M | 172.825 ± 3.715 | 148.956 ± 4.235 | <0.001 |
| M — Se | 148.956 ± 4.235 | 156.173 ± 1.685 | 0.039 | |
| M — D1 | 148.956 ± 4.235 | 73.068 ± 1.841 | <0.001 | |
| M — D2 | 148.956 ± 4.235 | 89.649 ± 1.747 | 0.001 | |
| M — D3 | 148.956 ± 4.235 | 118.062 ± 1.585 | 0.002 | |
| M — D4 | 148.956 ± 4.235 | 143.714 ± 3.145 | 0.014 | |
| D1 — SD1 | 73.068 ± 1.841 | 74.280 ± 2.008 | 0.006 | |
| D2 — SD2 | 89.649 ± 1.747 | 91.678 ± 2.932 | 0.097 | |
| D3 — SD3 | 118.062 ± 1.585 | 122.214 ± 2.665 | 0.022 | |
| D4 — SD4 | 143.714 ± 3.145 | 145.834 ± 2.895 | 0.005 | |
| 24 h | P — M | 154.714 ± 3.225 | 130.376 ± 2.065 | 0.001 |
| M — Se | 130.376 ± 2.065 | 140.390 ± 2.380 | <0.001 | |
| M — D1 | 130.376 ± 2.065 | 53.646 ± 2.155 | <0.001 | |
| M — D2 | 130.376 ± 2.065 | 72.114 ± 2.847 | <0.001 | |
| M — D3 | 130.376 ± 2.065 | 94.263 ± 1.722 | <0.001 | |
| M — D4 | 130.376 ± 2.065 | 120.947 ± 2.861 | 0.002 | |
| D1 — SD1 | 53.646 ± 2.155 | 55.415 ± 1.853 | 0.010 | |
| D2 — SD2 | 72.114 ± 2.847 | 77.168 ± 1.659 | 0.018 | |
| D3 — SD3 | 94.263 ± 1.722 | 102.263 ± 2.389 | 0.002 | |
| D4 — SD4 | 120.947 ± 2.861 | 125.143 ± 2.625 | 0.001 | |
Rates of change in the H2O2 contents of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| Groups | The change rates of H2O2(%) | ||
|---|---|---|---|
| 6 h | 12 h | 24 h | |
| KG-A1 | −1.917 | −2.598 | −5.176 |
| NG-A1 | −2.852 | −3.877 | −5.525 |
| KG-A2 | −3.289 | −6.008 | −8.123 |
| NG-A2 | −5.263 | −7.281 | −5.863 |
| KG-A3 | −4.968 | −6.737 | −14.443 |
| NG-A3 | −6.245 | −8.660 | −14.864 |
| KG-A4 | −12.160 | −4.397 | −19.517 |
| NG-A4 | −2.354 | −5.215 | −19.201 |
Rates of change in the capacities of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes to inhibit hydroxyl radicals at 6, 12, and 24 h after treatment.
| Groups | The change rates of inhibition of hydroxyl radical (%) | ||
|---|---|---|---|
| 6 h | 12 h | 24 h | |
| KG-A1 | 0.739 | 1.659 | 3.288 |
| NG-A1 | 1.189 | 2.261 | 5.863 |
| KG-A2 | 1.522 | 2.263 | 7.007 |
| NG-A2 | 2.396 | 4.188 | 9.276 |
| KG-A3 | 2.689 | 3.517 | 8.486 |
| NG-A3 | 4.788 | 5.704 | 10.520 |
| KG-A4 | 0.731 | 1.475 | 3.469 |
| NG-A4 | 1.033 | 3.149 | 5.068 |
Effects of DON and/or Na2SeO3 on the levels of ROS in GPX1-knockdown porcine splenic lymphocytes at 24 h after treatment.
| ROS content | ||||
|---|---|---|---|---|
| Time | pairing | median |
| |
| 24 h | P — M | 847.00 ± 42.00 | 1069.00 ± 52.00 | 0.001 |
| M — Se | 1069.00 ± 52.00 | 893.33 ± 22.50 | 0.009 | |
| M — D1 | 1069.00 ± 52.00 | 1426.33 ± 37.50 | 0.001 | |
| M — D2 | 1069.00 ± 52.00 | 1320.33 ± 41.50 | 0.001 | |
| M — D3 | 1069.00 ± 52.00 | 1241.33 ± 61.50 | 0.001 | |
| M — D4 | 1069.00 ± 52.00 | 1060.00 ± 67.00 | 0.408 | |
| D1 — SD1 | 1426.33 ± 37.50 | 1390.00 ± 27.00 | 0.027 | |
| D2 — SD2 | 1320.33 ± 41.50 | 1271.33 ± 47.50 | 0.005 | |
| D3 — SD3 | 1241.33 ± 61.50 | 1083.66 ± 95.00 | 0.015 | |
| D4 — SD4 | 1060.00 ± 67.00 | 1078.00 ± 45.00 | 0.276 | |
Concentrations of transfection reagent and siRNA.
| Combination | names | ① | ② | ③ | ④ |
|---|---|---|---|---|---|
| reagent | 10 μL | 12 μL | 14 μL | 16 μL | |
| Positive siRNA(with FAM) | GPx1 | 12 nmol/L | 18 nmol/L | 24 nmol/L | 30 nmol/L |
Effects of DON and/or Na2SeO3 on the levels of MDA in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| MDA (nmol/mg.prot) | ||||
|---|---|---|---|---|
| time | pairing | content |
| |
| 6 h | P — M | 7.144 ± 0.027 | 7.584 ± 0.088 | 0.006 |
| M — Se | 7.584 ± 0.088 | 7.353 ± 0.060 | 0.005 | |
| M — D1 | 7.584 ± 0.088 | 10.276 ± 0.089 | <0.001 | |
| M — D2 | 7.584 ± 0.088 | 8.812 ± 0.042 | <0.001 | |
| M — D3 | 7.584 ± 0.088 | 8.114 ± 0.065 | 0.001 | |
| M — D4 | 7.584 ± 0.088 | 7.487 ± 0.066 | 0.017 | |
| D1 — SD1 | 10.276 ± 0.089 | 10.152 ± 0.132 | 0.037 | |
| D2 — SD2 | 8.812 ± 0.042 | 8.586 ± 0.127 | 0.045 | |
| D3 — SD3 | 8.114 ± 0.065 | 7.851 ± 0.072 | <0.001 | |
| D4 — SD4 | 14.527 ± 0.632 | 7.348 ± 0.073 | 0.001 | |
| 12 h | P — M | 7.573 ± 0.057 | 8.374 ± 0.098 | 0.001 |
| M — Se | 8.374 ± 0.098 | 8.108 ± 0.137 | 0.007 | |
| M — D1 | 8.374 ± 0.098 | 11.717 ± 0.195 | <0.001 | |
| M — D2 | 8.374 ± 0.098 | 10.398 ± 0.161 | <0.001 | |
| M — D3 | 8.374 ± 0.098 | 9.432 ± 0.086 | <0.001 | |
| M — D4 | 8.374 ± 0.098 | 8.521 ± 0.074 | 0.009 | |
| D1 — SD1 | 11.717 ± 0.195 | 11.489 ± 0.270 | 0.034 | |
| D2 — SD2 | 10.398 ± 0.161 | 10.111 ± 0.190 | 0.003 | |
| D3 — SD3 | 9.432 ± 0.086 | 9.074 ± 0.198 | 0.031 | |
| D4 — SD4 | 8.521 ± 0.074 | 8.105 ± 0.186 | 0.023 | |
| 24 h | P — M | 8.192 ± 0.109 | 9.207 ± 0.724 | 0.104 |
| M — Se | 9.207 ± 0.724 | 8.940 ± 0.082 | 0.546 | |
| M — D1 | 9.207 ± 0.724 | 12.872 ± 0.260 | 0.005 | |
| M — D2 | 9.207 ± 0.724 | 11.878 ± 0.245 | 0.011 | |
| M — D3 | 9.207 ± 0.724 | 11.011 ± 0.046 | 0.044 | |
| M — D4 | 9.207 ± 0.724 | 10.201 ± 0.160 | 0.093 | |
| D1 — SD1 | 12.872 ± 0.260 | 12.435 ± 0.235 | 0.001 | |
| D2 — SD2 | 11.878 ± 0.245 | 10.923 ± 0.274 | <0.001 | |
| D3 — SD3 | 11.011 ± 0.046 | 10.327 ± 0.237 | 0.025 | |
| D4 — SD4 | 10.201 ± 0.160 | 9.439 ± 0.108 | 0.002 | |
Effects of DON and/or Na2SeO3 on SOD activity in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| SOD activities(U/mg.prot) | ||||
|---|---|---|---|---|
| time | pairing | activities |
| |
| 6 h | P — M | 52.592 ± 1.104 | 47.394 ± 0.872 | 0.001 |
| M — Se | 47.394 ± 0.872 | 48.646 ± 0.653 | 0.010 | |
| M — D1 | 47.394 ± 0.872 | 31.763 ± 0.340 | <0.001 | |
| M — D2 | 47.394 ± 0.872 | 37.786 ± 0.272 | 0.001 | |
| M — D3 | 47.394 ± 0.872 | 44.982 ± 0.590 | 0.005 | |
| M — D4 | 47.394 ± 0.872 | 47.700 ± 0.816 | 0.011 | |
| D1 — SD1 | 31.763 ± 0.340 | 31.923 ± 0.399 | 0.042 | |
| D2 — SD2 | 37.786 ± 0.272 | 38.516 ± 0.657 | 0.082 | |
| D3 — SD3 | 44.982 ± 0.590 | 46.158 ± 0.565 | <0.001 | |
| D4 — SD4 | 47.700 ± 0.816 | 49.241 ± 0.803 | <0.001 | |
| 12 h | P — M | 46.305 ± 0.566 | 43.505 ± 0.502 | <0.001 |
| M — Se | 43.505 ± 0.502 | 45.169 ± 0.697 | 0.005 | |
| M — D1 | 43.505 ± 0.502 | 25.931 ± 0.364 | <0.001 | |
| M — D2 | 43.505 ± 0.502 | 33.502 ± 0.307 | <0.001 | |
| M — D3 | 43.505 ± 0.502 | 37.588 ± 0.596 | <0.001 | |
| M — D4 | 43.505 ± 0.502 | 40.446 ± 0.595 | <0.001 | |
| D1 — SD1 | 25.931 ± 0.364 | 26.253 ± 0.435 | 0.016 | |
| D2 — SD2 | 33.502 ± 0.307 | 34.266 ± 0.537 | 0.029 | |
| D3 — SD3 | 37.588 ± 0.596 | 38.659 ± 0.387 | 0.012 | |
| D4 — SD4 | 40.446 ± 0.595 | 43.253 ± 0.503 | <0.001 | |
| 24 h | P — M | 39.245 ± 0.427 | 32.629 ± 0.546 | <0.001 |
| M — Se | 32.629 ± 0.546 | 33.907 ± 0.531 | <0.001 | |
| M — D1 | 32.629 ± 0.546 | 16.264 ± 0.229 | <0.001 | |
| M — D2 | 32.629 ± 0.546 | 18.606 ± 0.140 | <0.001 | |
| M — D3 | 32.629 ± 0.546 | 21.386 ± 0.347 | <0.001 | |
| M — D4 | 32.629 ± 0.546 | 25.740 ± 0.231 | 0.001 | |
| D1 — SD1 | 16.264 ± 0.229 | 16.870 ± 0.248 | <0.001 | |
| D2 — SD2 | 18.606 ± 0.140 | 19.399 ± 0.368 | 0.026 | |
| D3 — SD3 | 21.386 ± 0.347 | 25.551 ± 0.500 | <0.001 | |
| D4 — SD4 | 25.740 ± 0.231 | 30.201 ± 0.334 | <0.001 | |
Effects of DON and/or Na2SeO3 on the CAT activity in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| CAT activities(U/mgprot) | ||||
|---|---|---|---|---|
| time | pairing | activities |
| |
| 6 h | P — M | 8.864 ± 0.060 | 8.132 ± 0.059 | <0.001 |
| M — Se | 8.132 ± 0.059 | 8.212 ± 0.032 | 0.036 | |
| M — D1 | 8.132 ± 0.059 | 5.826 ± 0.029 | <0.001 | |
| M — D2 | 8.132 ± 0.059 | 6.102 ± 0.029 | <0.001 | |
| M — D3 | 8.132 ± 0.059 | 6.832 ± 0.033 | <0.001 | |
| M — D4 | 8.132 ± 0.059 | 8.168 ± 0.111 | 0.357 | |
| D1 — SD1 | 5.826 ± 0.029 | 5.893 ± 0.019 | 0.007 | |
| D2 — SD2 | 6.102 ± 0.029 | 6.522 ± 0.006 | 0.001 | |
| D3 — SD3 | 6.832 ± 0.033 | 6.990 ± 0.013 | 0.005 | |
| D4 — SD4 | 8.168 ± 0.111 | 8.357 ± 0.109 | <0.001 | |
| 12 h | P — M | 8.594 ± 0.068 | 7.725 ± 0.037 | <0.001 |
| M — Se | 7.725 ± 0.037 | 8.079 ± 0.077 | 0.004 | |
| M — D1 | 7.725 ± 0.037 | 4.858 ± 0.044 | <0.001 | |
| M — D2 | 7.725 ± 0.037 | 5.628 ± 0.034 | <0.001 | |
| M — D3 | 7.725 ± 0.037 | 6.185 ± 0.006 | <0.001 | |
| M — D4 | 7.725 ± 0.037 | 7.448 ± 0.028 | <0.001 | |
| D1 — SD1 | 4.858 ± 0.044 | 5.111 ± 0.020 | 0.012 | |
| D2 — SD2 | 5.628 ± 0.034 | 6.064 ± 0.007 | 0.001 | |
| D3 — SD3 | 6.185 ± 0.006 | 6.567 ± 0.036 | 0.002 | |
| D4 — SD4 | 7.448 ± 0.028 | 8.063 ± 0.059 | 0.001 | |
| 24 h | P — M | 7.493 ± 0.054 | 6.206 ± 0.552 | 0.061 |
| M — Se | 6.206 ± 0.552 | 6.349 ± 0.057 | 0.707 | |
| M — D1 | 6.206 ± 0.552 | 3.545 ± 0.005 | 0.014 | |
| M — D2 | 6.206 ± 0.552 | 3.901 ± 0.027 | 0.019 | |
| M — D3 | 6.206 ± 0.552 | 4.480 ± 0.029 | 0.034 | |
| M — D4 | 6.206 ± 0.552 | 5.416 ± 0.024 | 0.138 | |
| D1 — SD1 | 3.545 ± 0.005 | 3.817 ± 0.020 | 0.001 | |
| D2 — SD2 | 3.901 ± 0.027 | 4.438 ± 0.047 | <0.001 | |
| D3 — SD3 | 4.480 ± 0.029 | 5.289 ± 0.019 | <0.001 | |
| D4 — SD4 | 5.416 ± 0.024 | 5.573 ± 0.036 | 0.002 | |
Effects of DON and/or Na2SeO3 on the levels of GSH in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| GSH (umol/gprot) | ||||
|---|---|---|---|---|
| time | pairing | content |
| |
| 6 h | P — M | 239.414 ± 6.165 | 233.345 ± 3.805 | 0.047 |
| M — Se | 233.345 ± 3.805 | 233.260 ± 4.220 | 0.757 | |
| M — D1 | 233.345 ± 3.805 | 142.407 ± 3.220 | <0.001 | |
| M — D2 | 233.345 ± 3.805 | 168.664 ± 4.832 | <0.001 | |
| M — D3 | 233.345 ± 3.805 | 204.520 ± 4.570 | <0.001 | |
| M — D4 | 233.345 ± 3.805 | 226.293 ± 3.950 | <0.001 | |
| D1 — SD1 | 142.407 ± 3.220 | 142.290 ± 3.005 | 0.446 | |
| D2 — SD2 | 168.664 ± 4.832 | 168.965 ± 4.895 | 0.015 | |
| D3 — SD3 | 204.520 ± 4.570 | 205.786 ± 4.415 | 0.005 | |
| D4 — SD4 | 226.293 ± 3.950 | 226.867 ± 4.311 | 0.110 | |
| 12 h | P — M | 229.384 ± 5.665 | 222.599 ± 4.575 | 0.008 |
| M — Se | 222.599 ± 4.575 | 221.932 ± 5.550 | 0.358 | |
| M — D1 | 222.599 ± 4.575 | 126.747 ± 3.780 | <0.001 | |
| M — D2 | 222.599 ± 4.575 | 153.548 ± 3.495 | <0.001 | |
| M — D3 | 222.599 ± 4.575 | 179.396 ± 3.815 | <0.001 | |
| M — D4 | 222.599 ± 4.575 | 198.856 ± 4.415 | <0.001 | |
| D1 — SD1 | 126.747 ± 3.780 | 127.745 ± 2.195 | 0.389 | |
| D2 — SD2 | 153.548 ± 3.495 | 153.221 ± 1.760 | 0.772 | |
| D3 — SD3 | 179.396 ± 3.815 | 181.746 ± 2.890 | 0.048 | |
| D4 — SD4 | 198.856 ± 4.415 | 202.112 ± 3.990 | 0.006 | |
| 24 h | P — M | 176.528 ± 2.395 | 165.320 ± 3.455 | 0.003 |
| M — Se | 165.320 ± 3.455 | 169.596 ± 2.640 | 0.012 | |
| M — D1 | 165.320 ± 3.455 | 97.760 ± 1.326 | <0.001 | |
| M — D2 | 165.320 ± 3.455 | 113.939 ± 2.205 | <0.001 | |
| M — D3 | 165.320 ± 3.455 | 133.746 ± 3.235 | <0.001 | |
| M — D4 | 165.320 ± 3.455 | 148.813 ± 3.545 | <0.001 | |
| D1 — SD1 | 97.760 ± 1.326 | 108.301 ± 2.090 | 0.002 | |
| D2 — SD2 | 113.939 ± 2.205 | 131.858 ± 3.510 | 0.002 | |
| D3 — SD3 | 133.746 ± 3.235 | 147.576 ± 2.850 | <0.001 | |
| D4 — SD4 | 148.813 ± 3.545 | 156.226 ± 2.585 | 0.006 | |
Effects of DON and/or Na2SeO3 on T-AOC in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| T-AOC (U/mg.prot) | ||||
|---|---|---|---|---|
| time | pairing | numerical |
| |
| 6 h | P — M | 35.412 ± 0.445 | 32.571 ± 0.464 | <0.001 |
| M — Se | 32.571 ± 0.464 | 32.749 ± 0.422 | 0.018 | |
| M — D1 | 32.571 ± 0.464 | 17.694 ± 0.257 | <0.001 | |
| M — D2 | 32.571 ± 0.464 | 19.262 ± 0.233 | <0.001 | |
| M — D3 | 32.571 ± 0.464 | 22.818 ± 0.189 | <0.001 | |
| M — D4 | 32.571 ± 0.464 | 31.748 ± 0.386 | 0.003 | |
| D1 — SD1 | 17.694 ± 0.257 | 18.089 ± 0.259 | <0.001 | |
| D2 — SD2 | 19.262 ± 0.233 | 19.759 ± 0.252 | <0.001 | |
| D3 — SD3 | 22.818 ± 0.189 | 23.566 ± 0.324 | 0.011 | |
| D4 — SD4 | 31.748 ± 0.386 | 32.308 ± 0.343 | 0.002 | |
| 12 h | P — M | 23.787 ± 0.314 | 20.108 ± 0.212 | <0.001 |
| M — Se | 20.108 ± 0.212 | 21.821 ± 0.252 | <0.001 | |
| M — D1 | 20.108 ± 0.212 | 9.731 ± 0.094 | <0.001 | |
| M — D2 | 20.108 ± 0.212 | 10.618 ± 0.106 | <0.001 | |
| M — D3 | 20.108 ± 0.212 | 14.833 ± 0.271 | <0.001 | |
| M — D4 | 20.108 ± 0.212 | 17.613 ± 0.219 | <0.001 | |
| D1 — SD1 | 9.731 ± 0.094 | 10.002 ± 0.139 | 0.009 | |
| D2 — SD2 | 10.618 ± 0.106 | 11.025 ± 0.111 | <0.001 | |
| D3 — SD3 | 14.833 ± 0.271 | 15.449 ± 0.170 | 0.009 | |
| D4 — SD4 | 17.613 ± 0.219 | 19.087 ± 0.353 | 0.003 | |
| 24 h | P — M | 15.915 ± 0.167 | 13.107 ± 0.169 | <0.001 |
| M — Se | 13.107 ± 0.169 | 15.327 ± 0.184 | <0.001 | |
| M — D1 | 13.107 ± 0.169 | 5.928 ± 0.064 | <0.001 | |
| M — D2 | 13.107 ± 0.169 | 6.647 ± 0.079 | <0.001 | |
| M — D3 | 13.107 ± 0.169 | 7.817 ± 0.089 | <0.001 | |
| M — D4 | 13.107 ± 0.169 | 9.373 ± 0.095 | <0.001 | |
| D1 — SD1 | 5.928 ± 0.064 | 6.374 ± 0.077 | <0.001 | |
| D2 — SD2 | 6.647 ± 0.079 | 7.586 ± 0.090 | <0.001 | |
| D3 — SD3 | 7.817 ± 0.089 | 9.350 ± 0.167 | 0.001 | |
| D4 — SD4 | 9.373 ± 0.095 | 11.210 ± 0.050 | <0.001 | |
Rates of change in the MDA content of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| Groups | The change rates of MDA(%) | ||
|---|---|---|---|
| 6 h | 12 h | 24 h | |
| KG-A1 | −1.207 | −1.946 | −3.395 |
| NG-A1 | −2.442 | −2.659 | −5.212 |
| KG-A2 | −2.565 | −2.760 | −8.065 |
| NG-A2 | −3.550 | −3.751 | −9.448 |
| KG-A3 | −3.241 | −3.785 | −6.212 |
| NG-A3 | −4.470 | −4.977 | −9.614 |
| KG-A4 | −1.857 | −4.882 | −7.460 |
| NG-A4 | −2.937 | −5.637 | −10.618 |
Rates of change in the SOD activity of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| Groups | The change rates of SOD(%) | ||
|---|---|---|---|
| 6 h | 12 h | 24 h | |
| KG-A1 | 0.504 | 1.241 | 3.726 |
| NG-A1 | 0.620 | 1.549 | 4.307 |
| KG-A2 | 1.923 | 2.279 | 4.263 |
| NG-A2 | 2.106 | 2.419 | 5.496 |
| KG-A3 | 2.614 | 2.848 | 19.475 |
| NG-A3 | 2.980 | 3.065 | 24.023 |
| KG-A4 | 3.231 | 6.887 | 17.331 |
| NG-A4 | 3.086 | 4.978 | 25.139 |
Rates of change in the CAT activity in GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| Groups | The change rates of CAT(%) | ||
|---|---|---|---|
| 6 h | 12 h | 24 h | |
| KG-A1 | 1.150 | 5.208 | 7.673 |
| NG-A1 | 5.345 | 5.780 | 9.308 |
| KG-A2 | 6.867 | 7.676 | 13.740 |
| NG-A2 | 8.320 | 9.964 | 18.559 |
| KG-A3 | 2.313 | 6.176 | 18.058 |
| NG-A3 | 10.657 | 12.255 | 19.103 |
| KG-A4 | 2.301 | 8.257 | 2.899 |
| NG-A4 | 2.222 | 10.774 | 12.278 |
Rates of change in the GSH content of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| Groups | The change rates of GSH(%) | ||
|---|---|---|---|
| 6 h | 12 h | 24 h | |
| KG-A1 | 0.082 | 0.079 | 10.783 |
| NG-A1 | 0.982 | 0.988 | 18.039 |
| KG-A2 | 0.179 | −0.213 | 15.727 |
| NG-A2 | 1.615 | 1.598 | 18.957 |
| KG-A3 | 0.619 | 1.310 | 29.742 |
| NG-A3 | 1.883 | 1.861 | 10.293 |
| KG-A4 | 0.254 | 1.637 | 4.981 |
| NG-A4 | 2.013 | 2.078 | 8.850 |
Rates of change in the T-AOC of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.
| Groups | The change rates of T-AOC(%) | ||
|---|---|---|---|
| 6 h | 12 h | 24 h | |
| KG-A1 | 2.226 | 2.788 | 7.521 |
| NG-A1 | 2.493 | 3.161 | 9.560 |
| KG-A2 | 2.575 | 3.837 | 14.126 |
| NG-A2 | 2.999 | 4.893 | 17.197 |
| KG-A3 | 3.276 | 4.155 | 19.611 |
| NG-A3 | 3.531 | 5.866 | 26.060 |
| KG-A4 | 1.176 | 8.369 | 19.599 |
| NG-A4 | 1.391 | 9.268 | 27.709 |